Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The anticoagulant protein C pathway.

Björn Dahlbäck1, Bruno O Villoutreix

  • 1Department of Laboratory Medicine, Clinical Chemistry, Lund University, The Wallenberg laboratory, University Hospital, Malmö, SE-205 02 Malmö, Sweden. bjorn.dahlback@klkemi.mas.lu.se

FEBS Letters
|June 10, 2005
PubMed
Summary

The protein C system regulates blood clotting and has anti-inflammatory roles. Genetic defects in this system increase the risk of venous thrombosis, highlighting its importance in hemostasis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The covalent docking software landscape: features and applications in drug design.

Briefings in bioinformatics·2025
Same author

Dapagliflozin's Association With Cardiorenal Outcomes and Apolipoprotein M Levels in HFrEF Patients: Insights From DEFINE-HF.

JACC. Advances·2025
Same author

Targeting TUBG1 in RB1-negative tumors.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2025
Same author

Importance of individual residues in hydrophobic patch PLVIVGL (1481-1487) in FV-Short for synergistic TFPIα cofactor activity with protein S, an alanine-scanning study: AlphaFold-mediated prediction of FV-Short/TFPIα/protein S trimolecular complex structure.

Journal of thrombosis and haemostasis : JTH·2024
Same author

Editor's Note: Therapeutic Targeting of Nuclear γ-Tubulin in RB1-Negative Tumors.

Molecular cancer research : MCR·2024
Same author

Targeting ERK-MYD88 interaction leads to ERK dysregulation and immunogenic cancer cell death.

Nature communications·2024

Area of Science:

  • Biochemistry
  • Hematology
  • Molecular Biology

Background:

  • The protein C system is a critical regulator of blood coagulation.
  • It involves multiple protein cofactors and receptors, including thrombin, thrombomodulin, and endothelial protein C receptor (EPCR).
  • Dysfunction in the protein C system is linked to thrombosis.

Purpose of the Study:

  • To review the molecular recognition mechanisms within the protein C system.
  • To elucidate the structure-function relationships of its multi-domain proteins.

Main Methods:

  • Review of existing literature on protein C system components.
  • Analysis of molecular interactions and recognition sites.
  • Discussion of genetic defects and their clinical implications.

Related Experiment Videos

Main Results:

  • The protein C system regulates coagulation factors Va and VIIIa via cleavage.
  • Activated protein C (APC) exerts anti-inflammatory and anti-apoptotic effects through EPCR and PAR-1.
  • Genetic defects in the protein C system are primary risk factors for venous thrombosis.

Conclusions:

  • The protein C system's intricate molecular recognition is essential for hemostasis and cellular protection.
  • Understanding these mechanisms is key to managing thrombotic disorders.